| Schedule of stockholders' equity |
The changes in stockholders’ equity for the prior year comparable period are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
Accumulated
Other |
|
|
|
|
|
|
Common Stock |
|
Paid-in |
|
Treasury Stock |
|
Comprehensive |
|
Retained |
|
|
|
|
Shares |
|
Amount |
|
Capital |
|
Shares |
|
Amount |
|
Loss |
|
Earnings |
|
Total |
|
Balance at September 30, 2024 |
|
36,707,840 |
|
$ |
37 |
|
$ |
275,771 |
|
|
(6,015,496 |
) |
$ |
(93,854 |
) |
$ |
(9,427 |
) |
$ |
10,033 |
|
$ |
182,560 |
|
Net income |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
5,810 |
|
|
5,810 |
|
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units |
|
138,838 |
|
|
— |
|
|
114 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
114 |
|
Taxes paid associated with net settlement of stock compensation awards |
|
(30,575 |
) |
|
— |
|
|
(883 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(883 |
) |
Forfeitures of restricted stock awards |
|
(22,500 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Shares swapped to exercise stock options |
|
— |
|
|
— |
|
|
19 |
|
|
(582 |
) |
|
(19 |
) |
|
— |
|
|
— |
|
|
— |
|
Stock compensation expense |
|
— |
|
|
— |
|
|
3,431 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
3,431 |
|
Foreign currency translation and other |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1,871 |
) |
|
— |
|
|
(1,871 |
) |
Balance at December 31, 2024 |
|
36,793,603 |
|
$ |
37 |
|
$ |
278,452 |
|
|
(6,016,078 |
) |
$ |
(93,873 |
) |
$ |
(11,298 |
) |
$ |
15,843 |
|
$ |
189,161 |
|
Net income |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
7,051 |
|
|
7,051 |
|
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units |
|
522,121 |
|
|
— |
|
|
78 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
78 |
|
Taxes paid associated with net settlement of stock compensation awards |
|
(119,819 |
) |
|
— |
|
|
(3,957 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(3,957 |
) |
Acquisition consideration paid in common stock (Note 3) |
|
27,260 |
|
|
|
|
945 |
|
|
|
|
|
|
|
|
|
|
945 |
|
Shares swapped to exercise stock options |
|
— |
|
|
— |
|
|
28 |
|
|
(815 |
) |
|
(28 |
) |
|
— |
|
|
— |
|
|
— |
|
Stock compensation expense |
|
— |
|
|
— |
|
|
2,578 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
2,578 |
|
Foreign currency translation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
469 |
|
|
— |
|
|
469 |
|
Balance at March 31, 2025 |
|
37,223,165 |
|
$ |
37 |
|
$ |
278,124 |
|
|
(6,016,893 |
) |
$ |
(93,901 |
) |
$ |
(10,829 |
) |
$ |
22,894 |
|
$ |
196,325 |
|
Net income |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
7,410 |
|
|
7,410 |
|
Exercise of common stock options, grants of restricted stock awards, and vesting of restricted stock units |
|
34,554 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Taxes paid associated with net settlement of stock compensation awards |
|
(9,442 |
) |
|
— |
|
|
(266 |
) |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(266 |
) |
Stock compensation expense |
|
— |
|
|
— |
|
|
3,512 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
3,512 |
|
Foreign currency translation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
1,669 |
|
|
— |
|
|
1,669 |
|
Balance at June 30, 2025 |
|
37,248,277 |
|
$ |
37 |
|
$ |
281,370 |
|
|
(6,016,893 |
) |
$ |
(93,901 |
) |
$ |
(9,160 |
) |
$ |
30,304 |
|
$ |
208,650 |
|
|
| Summary of share-based compensation expense |
The table below presents the components of share-based compensation expense (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Nine Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Equity-classified awards: |
|
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
$ |
853 |
|
|
$ |
563 |
|
|
$ |
2,579 |
|
|
$ |
1,595 |
|
RSUs & RSAs |
|
|
4,419 |
|
|
|
2,949 |
|
|
|
13,217 |
|
|
|
7,927 |
|
Total Equity-classified awards |
|
$ |
5,272 |
|
|
$ |
3,512 |
|
|
$ |
15,796 |
|
|
$ |
9,522 |
|
The table below presents the components of share-based compensation expense by line-item within our Condensed Consolidated Statements of Operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Nine Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Stock compensation expense by function |
|
|
|
|
|
|
|
|
|
|
|
|
Technology and operations |
|
$ |
826 |
|
|
$ |
581 |
|
|
$ |
2,449 |
|
|
$ |
1,559 |
|
Sales and marketing |
|
|
1,602 |
|
|
|
1,142 |
|
|
|
4,935 |
|
|
|
3,016 |
|
General and administrative |
|
|
2,844 |
|
|
|
1,789 |
|
|
|
8,412 |
|
|
|
4,947 |
|
Total stock compensation expense: |
|
$ |
5,272 |
|
|
$ |
3,512 |
|
|
$ |
15,796 |
|
|
$ |
9,522 |
|
|